Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 10, 2026 · Filed Nov 12, 2026
A Phio Pharmaceuticals director paid $5.7K out of pocket for Phio Pharmaceuticals shares. 2 other people at Phio Pharmaceuticals bought some too, in the same month. It was the first purchase in over a year.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$5,709
Shares × reported transaction price
<$25K
+18.0%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
None in 18 months of history
Confirmed open-market purchases by the same insider in the available history
3 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
5 days after results of Nov 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $0.8138 on Nov 10, 2026, within 2% of its 52-week low, after a 21% drop over the previous 30 trading days
52-week range $0.80 (Nov 5, 2026) to $1.65 (Feb 13, 2026), 2% of the way up, from 251 adjusted closes. 30 trading days earlier: $1.03 on Sep 29, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
3 PHIO insiders bought within the same week. That happened twice before in filings since 2013: Aug 2013 and Sep 2026. David H Deming's first open-market purchase of PHIO in filings since 2013
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
Insider buying
3 insiders in a week, 3rd time since 2013Traded Nov 11 · filed 1 day later
A Phio Pharmaceuticals director paid $4.4K out of pocket for Phio Pharmaceuticals shares. 2 other people at Phio Pharmaceuticals bought some too, in the same month. Shares held went up 12% with this purchase.
Insider buying
Their largest buy since 2013Traded Nov 9 · filed 1 day later
The CEO of Phio Pharmaceuticals paid $21K out of pocket for Phio Pharmaceuticals shares. 2 other people at Phio Pharmaceuticals bought some too, in the same month.
Insider buying
Traded Nov 9 · filed 1 day later
A Phio Pharmaceuticals director paid $15K out of pocket for Phio Pharmaceuticals shares. 2 other people at Phio Pharmaceuticals bought some too, in the same month. Shares held went up 44% with this purchase.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.